This was the stock's third consecutive day of losses.

The teen is the first student from Levittown's General Douglas MacArthur High School to be named a finalist in the ...

Jonathon Whitton, AuD, PhD, VP, auditory global program head, Regeneron, discusses regulatory challenges for DB-OTO, Regeneron’s AAV-based gene therapy for hearing loss.

Despite early success, Verona's lack of specific 2025 guidance and competition from Dupixent and other drugs raise concerns.

Matteo Paz built a machine-learning algorithm in high school to analyze heaps of data for NASA. He just won a $250,000 ...

Celestial discoveries: Paz won the $250,000 top prize for his research on detecting objects in the night sky. Using ...

We hear from the student winners of the prestigious Regeneron Science Talent Search, America's oldest science and math ...

For current and former smokers, statins may reduce the amount of chest muscle loss, while aspirin may contribute to increased chest muscle loss, according to a new study.

Patients with asthma who used depemokimab tolerated treatment well while experiencing reductions in rates of clinically ...

The RNA inhibitor reduces levels of oxidized phospholipids, which are presumed to promote atherosclerosis, by more than 93%.

TD Cowen analyst Tyler Van Buren maintained a Buy rating on Cartesian Therapeutics (RNAC – Research Report) today. The company’s shares opened ...

Shift Bioscience, a Cambridge biotech using an AI powered virtual cell to fight age-related diseases, has made two shrewd hires as it advances its technology. The company has appointed Jill Reckless ...